Zevra Therapeutics, Inc. SEC filings ZVRA
Zevra Therapeutics, Inc. has 870 filings in SEC EDGAR's recent list, going back to May 6, 2008. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| DEF 14A | Proxy statement | Apr 20, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Regulation FD disclosure
|
Mar 16, 2026 | Mar 12, 2026 |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 9, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 2, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 20, 2025 | Nov 20, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2025 | May 29, 2025 |
| DEFA14A | Additional proxy material | May 21, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| DEFA14A | Additional proxy material | May 8, 2025 | — |
| DEFC14A | Filing | Apr 29, 2025 | — |
| PRRN14A | Filing | Apr 24, 2025 | — |
| DFAN14A | Filing | Apr 23, 2025 | — |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| DEFC14A | Filing | Apr 21, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| PRRN14A | Filing | Apr 16, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2025 | — |
| PREC14A | Filing | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Results of operations, Other events
|
Apr 7, 2025 | Apr 1, 2025 |
| DEFA14A | Additional proxy material | Mar 31, 2025 | — |
| DEFA14A | Additional proxy material | Mar 31, 2025 | — |
| PREC14A | Filing | Mar 31, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 27, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 22, 2024 | Nov 21, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 8, 2024 |
| 424B5 | Prospectus supplement | Aug 9, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 424B5 | Prospectus supplement | Aug 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 5, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 12, 2024 | Jul 12, 2024 |
| 424B2 | Prospectus | Jul 12, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| EFFECT | Filing | Jun 13, 2024 | — |
| CORRESP | Letter to the SEC | Jun 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2024 | — |
| S-3 | Shelf registration | Jun 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
Apr 10, 2024 | Apr 4, 2024 |
| EFFECT | Filing | Apr 8, 2024 | — |
| S-3/A | Filing | Apr 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 4, 2024 | — |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 13, 2024 |
| S-8 | Employee stock plan registration | Apr 2, 2024 | — |
| S-8 | Employee stock plan registration | Apr 2, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Restatement
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 27, 2024 | Mar 26, 2024 |
| CORRESP | Letter to the SEC | Mar 6, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 28, 2024 | Feb 22, 2024 |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2024 | — |
| S-3 | Shelf registration | Feb 5, 2024 | — |
| 8-K/A | Amended current report | Feb 5, 2024 | Nov 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 27, 2023 | Dec 22, 2023 |
| 424B5 | Prospectus supplement | Nov 22, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 425 | Form 425 | Oct 30, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| EFFECT | Filing | Oct 10, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2023 | Oct 7, 2023 |
| 424B3 | Prospectus | Oct 10, 2023 | — |
| CORRESP | Letter to the SEC | Oct 6, 2023 | — |
| S-4/A | Filing | Oct 6, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2023 | — |
| S-4 | Registration for a merger or exchange | Sep 29, 2023 | — |
| DEFA14A | Additional proxy material | Aug 31, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 31, 2023 |
| 425 | Filing | Aug 31, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 31, 2023 | Aug 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2023 | Aug 7, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 15, 2023 | May 13, 2023 |
| 8-K |
Current report
Officer or director change
|
May 8, 2023 | May 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Apr 26, 2023 | Apr 25, 2023 |
| DEFA14A | Additional proxy material | Apr 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 5, 2023 | — |
| DEFA14A | Additional proxy material | Apr 3, 2023 | — |
| DEFA14A | Additional proxy material | Mar 30, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2023 | Mar 27, 2023 |
| DEFA14A | Additional proxy material | Mar 29, 2023 | — |
| DEFA14A | Additional proxy material | Mar 29, 2023 | — |
| DEFA14A | Additional proxy material | Mar 29, 2023 | — |
| DEFC14A | Filing | Mar 17, 2023 | — |
| DEFA14A | Additional proxy material | Mar 17, 2023 | — |
| DEFA14A | Additional proxy material | Mar 16, 2023 | — |
| PRRN14A | Filing | Mar 16, 2023 | — |
| DEFA14A | Additional proxy material | Mar 15, 2023 | — |
| DEFC14A | Form defc14a | Mar 15, 2023 | — |
| PRER14A | Filing | Mar 13, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| UPLOAD | Letter from the SEC | Mar 10, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| 10-K | Annual report | Mar 7, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 7, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| PRER14A | Filing | Mar 6, 2023 | — |
| CORRESP | Letter to the SEC | Mar 6, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2023 | — |
| DFAN14A | Dfan 14a | Mar 3, 2023 | — |
| PREN14A | Filing | Mar 3, 2023 | Mar 3, 2023 |
| DEFA14A | Additional proxy material | Feb 27, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2023 | Feb 27, 2023 |
| PREC14A | Form prec14a | Feb 27, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 24, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 25, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Other events
|
Jan 20, 2023 | Jan 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 9, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 29, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Other events
|
Nov 18, 2022 | Nov 18, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 1, 2022 | Jun 28, 2022 |
| DEFA14A | Additional proxy material | Jun 17, 2022 | — |
| 8-K |
Current report
Auditor change
|
Jun 17, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt
|
Jun 1, 2022 | May 31, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 16, 2022 | May 15, 2022 |
| DEFA14A | Additional proxy material | May 12, 2022 | — |
| DEF 14A | Proxy statement | May 12, 2022 | Jun 28, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 21, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Other events
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2022 | Feb 22, 2022 |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| EFFECT | Filing | Feb 1, 2022 | — |
| POS EX | Filing | Jan 28, 2022 | — |
| POS AM | Filing | Jan 25, 2022 | — |
| 424B3 | Prospectus | Jan 20, 2022 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 19, 2022 | Jan 19, 2022 |
| 424B3 | Prospectus | Dec 20, 2021 | — |
| 8-K |
Current report
Other events
|
Dec 20, 2021 | Dec 20, 2021 |
| 424B3 | Prospectus | Dec 14, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 14, 2021 | Dec 14, 2021 |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 10, 2021 | Nov 5, 2021 |
| 424B3 | Prospectus | Oct 19, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 19, 2021 | Oct 19, 2021 |
| 424B3 | Prospectus | Aug 20, 2021 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 18, 2021 | Aug 18, 2021 |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 424B3 | Prospectus | Aug 13, 2021 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 424B3 | Prospectus | Jul 21, 2021 | — |
| 8-K |
Current report
Other events
|
Jul 21, 2021 | Jul 21, 2021 |
| EFFECT | Filing | Jul 12, 2021 | — |
| 424B5 | Prospectus supplement | Jul 12, 2021 | — |
| 424B5 | Prospectus supplement | Jul 12, 2021 | — |
| 424B3 | Prospectus | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZVRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1434647
- Former names
- KEMPHARM, INC (until Feb 24, 2023); KEMPHARM INC (until Jun 30, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.